Aadi Bioscience (AADI) News Today $2.04 +0.08 (+4.08%) As of 06/16/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AADI Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Whitehawk Therapeutics May 2025 slides: Pivoting to ADC development with three candidatesMay 16, 2025 | uk.investing.comMetastatic Colorectal Cancer Clinical Trial Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsightMay 14, 2025 | finance.yahoo.comMarginal Benefits in High-Risk Ovarian Cancer With Addition of Bevacizumab to ChemoMay 13, 2025 | msn.comFYARRO Sets New Standard in Rare Oncology Market with Strong Growth Prospects | DelveInsightApril 17, 2025 | finance.yahoo.comWhitehawk Therapeutics files to sell 41.67M shares of common stock for holdersApril 2, 2025 | markets.businessinsider.comWhitehawk Therapeutics Completes Strategic Transformation with Successful Closing of Sale of Aadi Subsidiary to Kaken PharmaceuticalsMarch 26, 2025 | finance.yahoo.comAadi Bioscience’s Earnings Call: Strategic Shifts and Promising PipelineMarch 21, 2025 | tipranks.comQ4 2024 Aadi Bioscience Inc Earnings CallMarch 20, 2025 | finance.yahoo.comWhitehawk Therapeutics: Strategic Shift and Financial OutlookMarch 19, 2025 | tipranks.comSix new option listings and four option delistings on March 19thMarch 19, 2025 | markets.businessinsider.comAadi Bioscience (NASDAQ:AADI) Posts Quarterly Earnings Results, Misses Estimates By $0.36 EPSAadi Bioscience (NASDAQ:AADI - Get Free Report) announced its quarterly earnings results on Tuesday. The company reported ($0.67) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.31) by ($0.36). Aadi Bioscience had a negative return on equity of 71.87% and a negative net margin of 246.06%.March 19, 2025 | marketbeat.comAadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC CompanyMarch 18, 2025 | finance.yahoo.comAadi Bioscience to Report Fourth Quarter and Full-Year 2024 Results and Corporate UpdateMarch 14, 2025 | prnewswire.comAadi Bioscience (AADI) to Release Quarterly Earnings on WednesdayAadi Bioscience (NASDAQ:AADI) will be releasing earnings before the market opens on Wednesday, March 12, Financial Modeling Prep reports.March 5, 2025 | marketbeat.comInsider Selling: Aadi Bioscience, Inc. (NASDAQ:AADI) CEO Sells 5,690 Shares of StockAadi Bioscience, Inc. (NASDAQ:AADI - Get Free Report) CEO David James Lennon sold 5,690 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $2.35, for a total value of $13,371.50. Following the completion of the sale, the chief executive officer now owns 33,429 shares in the company, valued at approximately $78,558.15. This represents a 14.55 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.March 4, 2025 | marketbeat.comAadi Bioscience Announces Closing of $100 Million PIPE FinancingMarch 4, 2025 | prnewswire.comAadi Bioscience, Inc. (NASDAQ:AADI) CEO Sells $13,371.50 in StockMarch 4, 2025 | insidertrades.comAadi Bioscience Announces Approval of All Proposals at Special Meeting of StockholdersMarch 3, 2025 | prnewswire.comAadi Bioscience to Present at the TD Cowen 45th Annual Healthcare ConferenceFebruary 24, 2025 | prnewswire.com3 US Penny Stocks With Market Caps Over $30M To WatchFebruary 21, 2025 | uk.finance.yahoo.comAadi Bioscience appoints Dornan as Chief Scientific OfficerFebruary 19, 2025 | markets.businessinsider.comAadi Bioscience Appoints David Dornan, PhD, as Chief Scientific OfficerFebruary 18, 2025 | prnewswire.comPeapod Lane Capital LLC Takes $1.40 Million Position in Aadi Bioscience, Inc. (NASDAQ:AADI)Peapod Lane Capital LLC purchased a new position in shares of Aadi Bioscience, Inc. (NASDAQ:AADI - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 442,942 shares of the company's stock, valued atFebruary 13, 2025 | marketbeat.comAadi Bioscience, Inc. (NASDAQ:AADI) Short Interest UpdateAadi Bioscience, Inc. (NASDAQ:AADI - Get Free Report) was the recipient of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 706,400 shares, a growth of 49.4% from the January 15th total of 472,700 shares. Approximately 3.5% of the company's stock are short sold. Based on an average daily trading volume, of 357,800 shares, the short-interest ratio is currently 2.0 days.February 13, 2025 | marketbeat.comAadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025February 5, 2025 | prnewswire.comShort Interest in Aadi Bioscience, Inc. (NASDAQ:AADI) Decreases By 13.7%Aadi Bioscience, Inc. (NASDAQ:AADI - Get Free Report) saw a large drop in short interest in January. As of January 31st, there was short interest totalling 472,700 shares, a drop of 13.7% from the January 15th total of 547,500 shares. Based on an average daily trading volume, of 349,100 shares, the days-to-cover ratio is currently 1.4 days. Approximately 2.3% of the company's shares are sold short.February 3, 2025 | marketbeat.comAadi Bioscience, Inc. (NASDAQ:AADI) Sees Large Increase in Short InterestAadi Bioscience, Inc. (NASDAQ:AADI - Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 547,500 shares, an increase of 136.0% from the December 31st total of 232,000 shares. Approximately 2.7% of the company's stock are sold short. Based on an average daily trading volume, of 322,600 shares, the days-to-cover ratio is presently 1.7 days.January 29, 2025 | marketbeat.comAadi Bioscience, Inc. (NASDAQ:AADI) Position Lowered by Jane Street Group LLCJane Street Group LLC lessened its holdings in Aadi Bioscience, Inc. (NASDAQ:AADI - Free Report) by 80.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 25,989 shares of the company's stock after seJanuary 16, 2025 | marketbeat.comAadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Up 136.0% in DecemberAadi Bioscience, Inc. (NASDAQ:AADI - Get Free Report) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 547,500 shares, a growth of 136.0% from the December 15th total of 232,000 shares. Currently, 2.7% of the shares of the stock are sold short. Based on an average daily volume of 322,600 shares, the days-to-cover ratio is currently 1.7 days.January 14, 2025 | marketbeat.comAadi Bioscience (NASDAQ:AADI) Shares Down 16.1% - What's Next?Aadi Bioscience (NASDAQ:AADI) Trading Down 16.1% - What's Next?January 14, 2025 | marketbeat.comAadi Bioscience Leads 3 Promising US Penny StocksDecember 23, 2024 | uk.finance.yahoo.comAadi Bioscience’s Strategic Agreements and Funding MovesDecember 21, 2024 | finance.yahoo.comAadi Bioscience stock soars on licensing and sale dealsDecember 20, 2024 | investing.comAadi Bioscience rockets 72% on key updatesDecember 20, 2024 | msn.comAadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE FinancingDecember 19, 2024 | prnewswire.comAadi Bioscience, Inc. (NASDAQ:AADI) Short Interest Down 8.8% in NovemberAadi Bioscience, Inc. (NASDAQ:AADI - Get Free Report) was the target of a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 256,500 shares, a decrease of 8.8% from the October 31st total of 281,100 shares. Based on an average daily volume of 148,600 shares, the short-interest ratio is currently 1.7 days. Currently, 1.3% of the shares of the company are sold short.December 2, 2024 | marketbeat.comUS Penny Stocks Under $90M Market Cap To WatchNovember 12, 2024 | finance.yahoo.comBML Capital Management LLC Buys Shares of 2,000,000 Aadi Bioscience, Inc. (NASDAQ:AADI)BML Capital Management LLC bought a new stake in Aadi Bioscience, Inc. (NASDAQ:AADI - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,000,000 shares of the company'sNovember 12, 2024 | marketbeat.comAadi Bioscience Faces Potential Financial Strain from Securities Class Action RisksNovember 9, 2024 | markets.businessinsider.comAadi Bioscience Reports Q3 2024 Earnings and GrowthNovember 7, 2024 | markets.businessinsider.comAadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate UpdateNovember 6, 2024 | prnewswire.comAadi Bioscience to Report Third Quarter 2024 Results and Corporate UpdateOctober 30, 2024 | prnewswire.comAadi Bioscience CEO sells shares worth $18,796October 5, 2024 | investing.comAadi Bioscience (NASDAQ:AADI) Stock, Short Interest ReportOctober 5, 2024 | benzinga.comDavid James Lennon Sells 9,689 Shares of Aadi Bioscience, Inc. (NASDAQ:AADI) StockOctober 4, 2024 | insidertrades.comWin for Perioperative Durvalumab in Muscle-Invasive Bladder CancerSeptember 17, 2024 | msn.comAadi Bioscience, Inc. (NASDAQ:AADI) Chairman Sells $68,400.00 in StockSeptember 8, 2024 | insidertrades.comAadi Bioscience stock downgraded to Neutral, PT reduced following trial outcomeAugust 29, 2024 | uk.investing.comPiper Sandler Downgrades Aadi Bioscience (AADI)August 28, 2024 | msn.comHold Rating for Aadi Bioscience Amid Clinical Setbacks and Modest Revenue ProjectionsAugust 27, 2024 | markets.businessinsider.com Get Aadi Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for AADI and its competitors with MarketBeat's FREE daily newsletter. Email Address AADI Media Mentions By Week AADI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AADI News Sentiment▼0.000.56▲Average Medical News Sentiment AADI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AADI Articles This Week▼01▲AADI Articles Average Week Get Aadi Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for AADI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VTYX News Today ELDN News Today PBYI News Today NMRA News Today INMB News Today DMAC News Today FATE News Today ALTS News Today ACTU News Today ENGN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AADI) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWhat 99% of investors are missing about Chinese AIChinese AI chatbot DeepSeek's release put the spotlight on AI and turned the tech world on its head. But 99...Weiss Ratings | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored72 Hours Until Musk’s $34 Trillion AI Network BeginsIn just 72 hours, Elon Musk is expected to flip the switch on Tesla’s autonomous network in Austin, Texas. ...The Oxford Club | SponsoredSorry about the swear wordWhat a huge few months for Bitcoin. First, Bitcoin hit $100,000… Then, Donald Trump pledged to create an...Manward Press | SponsoredPresident Trump Could Soon Unlock Trillions in New WealthIf you think America is broke, think again. These "reserve accounts" are worth trillions... And according t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aadi Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aadi Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
